These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6286863)

  • 1. Production of hepatitis B e antibody in Epstein-Barr virus-induced B lymphocyte cell lines.
    Furuya Y; Inoue M; Yoshida Y; Yoshihara N; Takada M
    J Med Virol; 1982; 9(4):293-7. PubMed ID: 6286863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of antibody to hepatitis Be antigen (anti-HBe) in HBsAg-negative individuals.
    Hess G; Arnold W; Gahl GM; Vogl E; Meyer zum Büschenfelde KH
    Vox Sang; 1981 Feb; 40(2):95-8. PubMed ID: 7233888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of the HBeAg/anti-HBe system in hepatitis B infection.
    Frösner GG
    Riv Emoter Immunoematol; 1980; 27(1-2):85-7. PubMed ID: 7466190
    [No Abstract]   [Full Text] [Related]  

  • 4. Reaction spectrum of HBe antibodies.
    Babeş VT; Tănase M
    Virologie; 1981; 32(1):3-7. PubMed ID: 7303490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of the antibody to hepatitis B e antigen by the inhibition on electrophoresis of free e antigen.
    Gotanda T; Imai M; Sano T; Oinuma A; Nomura M; Miyakawa Y; Mayumi M
    J Immunol Methods; 1982; 51(3):347-53. PubMed ID: 7108234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HBeAg and anti-HBe in chronic hepatitis B virus infection.
    Chen DS; Sung JL; Lai MY
    Gastroenterology; 1981 Apr; 80(4):880-2. PubMed ID: 7202958
    [No Abstract]   [Full Text] [Related]  

  • 7. The window period between hepatitis B e antigen and antibody in chronic type hepatitis.
    Liaw YF; Huang MJ; Chu CM; Sheen IS; Lin DY
    Hepatology; 1984; 4(4):619-21. PubMed ID: 6745849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The production of anti-HBc IgM antibodies by human lymphocytes transformed by the Epstein-Barr virus].
    Gurov AV; Favorov MO; Iashina TL; Gol'dberg EZ; Khizhniakova TM; Anan'ev VA
    Vopr Virusol; 1990; 35(4):306-8. PubMed ID: 2175065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Demonstration of two distinct antigenic determinants on hepatitis B e antigen by monoclonal antibodies.
    Imai M; Nomura M; Gotanda T; Sano T; Tachibana K; Miyamoto H; Takahashi K; Toyama S; Miyakawa Y; Mayumi M
    J Immunol; 1982 Jan; 128(1):69-72. PubMed ID: 6172494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro production of antibody to hepatitis B core and E antigens by peripheral blood mononuclear cells in patients with chronic hepatitis B virus infection.
    Tsutsumi Y; Kakumu S; Wakita T; Yoshioka K; Ishikawa T
    J Immunol; 1990 Mar; 144(6):2389-93. PubMed ID: 2313098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment of specific antibody producing human lines by antigen preselection and Epstein-Barr virus (EBV)-transformation.
    Steinitz M; Koskimies S; Klein G; Mäkelä O
    J Clin Lab Immunol; 1979 Apr; 2(1):1-7. PubMed ID: 95800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic hepatitis in HBsAg carriers with serum HBV-DNA and anti-HBe.
    Bonino F; Rosina F; Rizzetto M; Rizzi R; Chiaberge E; Tardanico R; Callea F; Verme G
    Gastroenterology; 1986 May; 90(5 Pt 1):1268-73. PubMed ID: 3956945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low frequency of cytotoxic liver-infiltrating T lymphocytes specific for endogenous processed surface and core proteins in chronic hepatitis B.
    Löhr HF; Gerken G; Schlicht HJ; Meryer zum Büschenfelde KH; Fleischer B
    J Infect Dis; 1993 Nov; 168(5):1133-9. PubMed ID: 8228346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr virus-induced lymphoblastoid cell lines from seropositive adult donors and their HLA-antigens.
    Akiyama N; Ohsawa N; Kusaba R; Inou T; Takada M
    Jpn J Exp Med; 1981 Feb; 51(1):1-7. PubMed ID: 6273617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reaction spectrum of anti-HBe and ABO blood groups.
    Babeş VT; Tănase M; Blană D
    Virologie; 1981; 32(1):81-2. PubMed ID: 6795815
    [No Abstract]   [Full Text] [Related]  

  • 16. Production of antibody associated with non-A, non-B hepatitis in a chimpanzee lymphoblastoid cell line established by in vitro transformation with Epstein-Barr virus.
    Shimizu YK; Oomura M; Abe K; Uno M; Yamada E; Ono Y; Shikata T
    Proc Natl Acad Sci U S A; 1985 Apr; 82(7):2138-42. PubMed ID: 2984683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human lymphoblastoid cell lines established from peripheral blood lymphocytes secreting immunoglobulins directed against herpes simplex virus.
    Evans L; Maragos C; May JT
    Immunol Lett; 1984; 8(1):39-42. PubMed ID: 6086505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of the cross-reactivity with hepatitis B virus antigens and antibodies for the demonstration of a woodchuck hepatitis virus 'e' antigen-antibody system.
    Hantz O; Pichoud C; Vitvitski L; Trepo C
    J Virol Methods; 1983 Jul; 7(1):45-55. PubMed ID: 6619256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radioimmunoassay for the detection of HBeAg and anti-HBe.
    Zanetti AR; Ferroni P; Bonino F; Recchia S; Aricò S; Palla M; Caspani B
    Boll Ist Sieroter Milan; 1979 Jan; 57(6):811-5. PubMed ID: 95390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical, virologic and histologic outcome following seroconversion from HBeAg to anti-HBe in chronic hepatitis type B.
    Fattovich G; Rugge M; Brollo L; Pontisso P; Noventa F; Guido M; Alberti A; Realdi G
    Hepatology; 1986; 6(2):167-72. PubMed ID: 3957228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.